Epigenetic Trends in Technology and Research
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences
He spoke to Pharma IQ about his recent report on Epigenetic research classes and Assay Trends with Genetic Engineering & Biotechnology News (GEN)
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.